Skip to main content

Closed

PTGX: Protagonist Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

93thpctl

Volume

0.77×avg

Market Cap

8.79BUSD

P/E Ratio

-75.8TTM

Div Yield

-ann

Protagonist Therapeutics, Inc.

PTGXNASDAQ Global Market·USD·Closed

Protagonist Therapeutics, Inc.

PTGXNASDAQ·USD·Closed

$136.64

−1.44%

$136.64

−$2.00 (1.44%)

52W Range

93thpctl

Volume

0.77×avg

Mkt Cap

8.79BUSD

P/E

-75.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings